Cefdinir and Zegerid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cefdinir (cefdinir) and Zegerid (omeprazole; sodium bicarbonate). Common drug interactions include chronic kidney disease among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Cefdinir and Zegerid. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Cefdinir?

Cefdinir has active ingredients of cefdinir. It is often used in sinusitis. eHealthMe is studying from 9,210 Cefdinir users. Check the latest studies of Cefdinir.

What is Zegerid?

Zegerid has active ingredients of omeprazole; sodium bicarbonate. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 3,220 Zegerid users. Check the latest studies of Zegerid.



On Jul, 07, 2026

12 people who take Cefdinir and Zegerid together, and have interactions are studied.

Cefdinir and Zegerid drug interactions.

What are the common drug interactions of Cefdinir and Zegerid, by gender? *:

female:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Renal injury (kidney injury)
  4. Abasia (inability to walk)
  5. Arteriospasm coronary (spasm of the large- or medium-sized coronary arteries)
  6. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  7. Arthropathy
  8. Back injury
  9. Blood glucose increased
  10. Blood homocysteine increased

male:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Obesity (having too much body fat)
  4. Renal injury (kidney injury)
  5. Thrombotic microangiopathy (a pathology that results in thrombosis in capillaries and arterioles, due to an endothelial injury)
  6. Benign prostatic hyperplasia (benign enlargement of the prostate)
  7. Cardiac failure
  8. Cardiac failure congestive
  9. Constipation
  10. Kidney infection

What are the common drug interactions of Cefdinir and Zegerid, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Chronic kidney disease
  2. Hypertension (high blood pressure)
  3. Hypocalcaemia (levels of calcium in blood serum are abnormally low)
  4. Hypokalaemia (low potassium)

30-39:

  1. Chronic kidney disease
  2. Nephropathy (damage to or disease of a kidney)
  3. Renal failure (kidney dysfunction)

40-49:

  1. Chronic kidney disease
  2. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  3. Renal failure (kidney dysfunction)

50-59:

  1. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)

60+:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Blood homocysteine increased
  4. Bone loss
  5. C-reactive protein increased
  6. Cardiac disorder
  7. Cardiac failure
  8. Cardiac failure congestive
  9. Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)
  10. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)

What are the existing conditions these people have? *

  1. Pain: 5 people, 41.67%
  2. Infection: 3 people, 25.00%
  3. Stress And Anxiety: 3 people, 25.00%
  4. High Blood Cholesterol: 3 people, 25.00%
  5. High Blood Pressure: 3 people, 25.00%
  6. Hypovitaminosis (any of several diseases caused by deficiency of one or more vitamins): 3 people, 25.00%
  7. Thyroid Diseases: 2 people, 16.67%
  8. Blood Uric Acid Increased: 2 people, 16.67%
  9. Cardiac Disorder: 2 people, 16.67%
  10. Cough: 2 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Cefdinir and Zegerid?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cefdinir and Zegerid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cefdinir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Zegerid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cefdinir and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zegerid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on cefdinir and omeprazole; sodium bicarbonate (the active ingredients of Cefdinir and Zegerid, respectively), and Cefdinir and Zegerid (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: